Results 121 to 130 of about 35,432 (258)

SEPLINE: Socioeconomic Position in Epidemiological Research—A National Guideline on Danish Registry Data

Clinical Epidemiology
Cathrine F Hjorth,1 Thora M Kjærulff,2 Mette K Thomsen,1,3 Deirdre Cronin-Fenton,1 Susanne O Dalton,4– 6 Maja H Olsen,4 The SEPLINE Group includes:Anne Dahl Sørensen, Cathrine F.
Hjorth CF, Kjærulff TM, Thomsen MK, Cronin-Fenton D, Dalton SO, Olsen MH   +5 more
doaj  

Distress Screening in a Cancer Survivorship Clinic: Impact on Psychosocial Referrals. [PDF]

J Adv Pract Oncol
Sloan H, Jennings SJ, Adair K, Stein A.
europepmc   +1 more source

The Testicular Cancer Consortium (TECAC): Filling Knowledge Gaps in the Genetic Etiology of Testicular Germ Cell Tumors

Andrology, EarlyView.
ABSTRACT Background The Testicular Cancer Consortium (TECAC) was established in 2012 and is comprised of researchers from over 25 centers in Europe and North America. TECAC's overarching goal is to investigate the genetic susceptibility of testicular germ cell tumors (TGCT) to better understand their biology, impact prevention strategies, and inform ...
Peter A. Kanetsky, Kristian Almstrup, Svetlana Cherlin, Victoria K. Cortessis, Alberto Ferlin, Jourik A. Gietema, Anna González‐Neira, Tom Grotmol, Robert J. Hamilton, Trine B. Haugen, Lambertus A. Kiemeney, Jung Kim, Csilla Krausz, Davor Lessel, Ragnhild A. Lothe, Kevin T. Nead, Jérémie Nsengimana, Jenny N. Poynter, Ewa Rajpert‐DeMeyts, Lorenzo Richiardi, Stephen M. Schwartz, Rolf I. Skotheim, Douglas R. Stewart, Clare Turnbull, Fredrik Wiklund, Tongzhang Zheng, Katherine L. Nathanson, Katherine A. McGlynn, for the Testicular Cancer Consortium   +28 more
wiley   +1 more source

Symptom burden in cancer survivorship: insights from a survivorship program's patient-reported outcomes database. [PDF]

Qual Life Res
Tlusty GC, Choi E, Alsbrook K, Gilmore KR, Rollins J, Dains J, Fadol A, Roth ME, Hacker ED.   +8 more
europepmc   +1 more source

A Spotlight on Yolk‐sac Tumors: Molecular Pathology, Current Diagnostics, and Novel Therapeutics

Andrology, EarlyView.
ABSTRACT Background Yolk‐sac tumors are an aggressive subtype of testicular cancer that significantly contribute to disease progression and therapy resistance, especially in adults. While testicular cancer generally has high cure rates with cisplatin‐based treatment, adult yolk‐sac tumors often appear as components of mixed tumors with poor response to
Evangelos Prokakis, Lisa Schneider, Felix Bremmer, Daniel Nettersheim   +3 more
wiley   +1 more source

Food and Nutrition Insecurity in Cancer Survivorship: A Global Scoping Review. [PDF]

Cancer Med
Ayre SK, Madders RJ, Baker BP, Mitchell EF, Goodwin BC, Johnston EA, Gallegos D.   +6 more
europepmc   +1 more source

Improving the Understanding of Late Effects of Testicular Cancer in Adolescent and Young Adult Survivors: TRANSCEND‐XR

Andrology, EarlyView.
ABSTRACT Background Testicular cancer (TC) is the most common malignancy amongst adolescents and young adults (AYAs) aged 15–39 years assigned male at birth. Survivors often experience late effects of treatment and report unmet supportive care needs.
Mohamad M. Saab, Josephine Hegarty, Jack P. Gleeson, David Murphy, Sheena McHugh, Frances Shiely, Aileen Murphy, Ann Kirby, Ida J. Korfage, Sophie Terhaard, Agnes van der Heide, Johannes Sivesgaard, Matias Katajavaara Seidler, Anna Patrikidou, Davor Ježek, Lynda Corrigan, Patrice Kearney Sheehan, Daniele Raggi, Alison Reid, Michal Chovanec, Patrizia Gianntempo, Jourik A. Gietema, Justine Fleur van der Feen, Francisco Lupiáñez‐Villanueva, Ana Roca‐Umbert, Joanne Reid, Paulo Alves, Joana Soares, Karen Galvin, Michal Kubo, Maria O'Malley   +30 more
wiley   +1 more source

Oncologist and General Practitioner Perspectives of Telehealth-Delivered Colorectal Cancer Survivorship Care. [PDF]

Psychooncology
Lisy K, Tieu M, Laing E, Gore C, Schofield P, Chan RJ, Emery J, Martin A, Lourenco RA, Jefford M.   +9 more
europepmc   +1 more source

Impact of Treatment Intensity on Quality of Life in Patients With Metastatic Testicular Cancer

Andrology, EarlyView.
ABSTRACT Introduction Testicular cancer (TC) is the most common malignancy in young men and is highly curable with platinum‐based chemotherapy. With growing survivorship rates, treatment‐related symptom burden and quality of life (QoL) have become increasingly important.
Pailin Pongratanakul, Tamim Hadjizada, Sophia Thy, Marieke Vermeulen‐Spohn, Günter Niegisch, Peter Albers, Yue Che   +6 more
wiley   +1 more source

Investing in prostate cancer survivorship. [PDF]

Can Urol Assoc J
Nguyen DD, Wallis CJD.
europepmc   +1 more source